Inventor
BARBERICH TIMOTHY J
US32 patents
⚠️ This page may combine multiple inventors who share the name “BARBERICH TIMOTHY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEPRACOR INC
30 patentsUS6369079B1Apr 9, 2002
Methods for treating irritable bowel syndrome using optically pure (+) norcisapride
SEPRACOR INC58 citations96
US5648396AJul 15, 1997
Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor
SEPRACOR INC56 citations96
US5362755ANov 8, 1994
Method for treating asthma using optically pure (R)-albuterol
SEPRACOR INC60 citations96
US5104899AApr 14, 1992
Methods and compositions for treating depression using optically pure fluoxetine
SEPRACOR INC97 citations96
US5919827AJul 6, 1999
Method for treating asthma using optically pure R(-) salmeterol
SEPRACOR INC39 citations93
US5589511ADec 31, 1996
Method for treating migraine headaches using optically pure S(+) fluoxetine
SEPRACOR INC33 citations93
US6835740B2Dec 28, 2004
Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride
SEPRACOR INC18 citations92
US6649183B2Nov 18, 2003
Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
SEPRACOR INC37 citations92
US6552045B2Apr 22, 2003
Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
SEPRACOR INC27 citations92
US6548518B2Apr 15, 2003
Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
SEPRACOR INC24 citations92
US6362202B1Mar 26, 2002
Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
SEPRACOR INC15 citations92
US5708035AJan 13, 1998
Methods of use and compositions of R(-) fluoxetine
SEPRACOR INC26 citations92
US5382591AJan 17, 1995
Antipyretic and analgesic methods using optically pure R-ketorolac
SEPRACOR INC33 citations92
US6548082B1Apr 15, 2003
Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
SEPRACOR INC13 citations84
US6083993AJul 4, 2000
Method for treating bronchospasm using optically pure R(-) albuterol
SEPRACOR INC16 citations84
US5547994AAug 20, 1996
Method for treating asthma using optically pure R(-) albuterol
SEPRACOR INC18 citations82
US6559165B1May 6, 2003
Methods for treating bulimia using optically pure (−) norcisapride
SEPRACOR INC11 citations74
US6353005B1Mar 5, 2002
Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
SEPRACOR INC12 citations74
US6048879AApr 11, 2000
Methods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisapride
SEPRACOR INC11 citations74
US5844002ADec 1, 1998
Method for inducing bronchodilation using optically pure R(-) albuterol
SEPRACOR INC9 citations74
US5760090AJun 2, 1998
Method for treating asthma using optically pure R(-) albuterol
SEPRACOR INC5 citations74
US5362757ANov 8, 1994
Composition and method containing optically pure (S) metoprolol
SEPRACOR INC8 citations74
US5190962AMar 2, 1993
Treating hypertension
SEPRACOR INC10 citations74
US5571827ANov 5, 1996
Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
SEPRACOR INC6 citations63
US7030142B1Apr 18, 2006
Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
SEPRACOR INC2 citations62
US7714023B2May 11, 2010
Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
SEPRACOR INC0 citations52
US7064138B2Jun 20, 2006
Methods for treating irritable bowel syndrome using optically pure (-) norcisapride
SEPRACOR INC0 citations52
US6465470B2Oct 15, 2002
R-hydroxynefazodone
SEPRACOR INC0 citations52
US6465469B1Oct 15, 2002
S-hydroxynefazodone
SEPRACOR INC0 citations52
US6384037B1May 7, 2002
R-hydroxynefazodone
SEPRACOR INC0 citations52